comparemela.com

Latest Breaking News On - Nucleic acid probe - Page 2 : comparemela.com

Meticulous Market Research Pvt. Ltd.: In-vitro Diagnostics Market to Reach $130.08 Billion by 2030 - Market Size, Share, Forecasts, & Trends Analysis Report by Meticulous Research®

REDDING, Calif., March 23, 2023 /PRNewswire/ According to a new market research report titled, 'In Vitro Diagnostics Market by Offering (Kits, Software), Technology (Immunoassay [ELISA],

Shenzhen
Guangdong
China
Khushal
Jizan
Saudi-arabia
Germany
Brazil
South-africa
Indonesia
France
Australia

In-vitro Diagnostics Market to Reach $130.08 Billion by 2030 - Market Size, Share, Forecasts, & Trends Analysis Report by Meticulous Research®

/PRNewswire/ According to a new market research report titled, In Vitro Diagnostics Market by Offering (Kits, Software), Technology (Immunoassay [ELISA],.

South-korea
Mexico
Argentina
California
United-states
Canada
Switzerland
Redding
Saudi-arabia
Australia
South-africa
Indonesia

Diagnostic Specialty Antibodies Market Worth $39.99 Billion by 2029 -- Exclusive Report by Meticulous Research®

/PRNewswire/ According to a new market research report titled, "Diagnostic Specialty Antibodies Market by Type (Primary, Secondary), Clonality (Monoclonal,.

Germany
California
United-states
Canada
France
Switzerland
Redding
America
Europe-ro
Technology-immunoassay
Agilent-technologies-inc

Immunoassay Market Worth $46.5 Billion by 2028, Growing at a CAGR of 7.5% From 2021- Exclusive Report by Meticulous Research®

Redding, California, June 04, 2021 (GLOBE NEWSWIRE) According to a new market research report "Immunoassay Market by Product & Solutions (Immunoassay .

Mexico
Germany
Australia
United-states
Redding
California
Brazil
China
Indonesia
Canada
Switzerland
France

Global In-Vitro Diagnostic Reagents (Antibodies, Oligonucleotide, Nucleic Acid Probe) Markets, 2020-2027

Share this article Share this article ResearchAndMarkets.com s offering. The IVD reagents market is expected to grow at a CAGR of 7% from 2020 to 2027 to reach $77.6 billion by 2027. The growth in the IVD reagents market is mainly attributed to the factors such as increasing global prevalence of acute and chronic infectious diseases coupled with rising geriatric population, increasing adoption of flow cytometry techniques in research and academia, increase in funding for research activities, and rising proteomics and genomics research studies. Moreover, the growing demand for protein therapeutics and personalized medicines and emerging economies offer significant growth opportunities for the players operating in this market.

China
Germany
United-states
Canada
Dublin
Ireland
France
America
Europe-ro
Asia-pacific-ro
Laura-wood
Technology-immunoassay

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.